Your browser doesn't support javascript.
loading
Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.
Anderson, Karen E; Stevenson, Max; Varghese, Rency; Hebron, Michaeline L; Koppel, Erin; McCartin, Mara; Kuprewicz, Robin; Matar, Sara; Ferrante, Dalila; Moussa, Charbel.
Affiliation
  • Anderson KE; MedStar Georgetown University Hospital Huntington's Disease Research, Education and Care Center, Department of Psychiatry and Department of Neurology, Georgetown University Medical Center, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Stevenson M; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Building D, Room 265, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Varghese R; Genomics and Epigenomics Shared Resource, Department of Oncology, Georgetown University Medical Center, Building D, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Hebron ML; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Building D, Room 265, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Koppel E; MedStar Georgetown University Hospital Huntington's Disease Research, Education and Care Center, Department of Psychiatry and Department of Neurology, Georgetown University Medical Center, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • McCartin M; MedStar Georgetown University Hospital Huntington's Disease Research, Education and Care Center, Department of Psychiatry and Department of Neurology, Georgetown University Medical Center, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Kuprewicz R; MedStar Georgetown University Hospital Huntington's Disease Research, Education and Care Center, Department of Psychiatry and Department of Neurology, Georgetown University Medical Center, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Matar S; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Building D, Room 265, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Ferrante D; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Building D, Room 265, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
  • Moussa C; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Building D, Room 265, 4000 Reservoir Rd, NW, Washington, DC 20057, USA.
Metabolites ; 12(12)2022 Dec 06.
Article in En | MEDLINE | ID: mdl-36557263
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Metabolites Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Metabolites Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland